LKFT 6-K: SEC filing
Lakefront Biotherapeutics
Filed with the SEC on · accession 0001171843-26-007340
LKFT filed a 6-K (foreign company report) with the SEC on Nov 12, 2026. Lakefront Biotherapeutics filed a Form 6-K attaching a press release dated November 10, 2026. The stock moved +1.8% by the first close after the filing.
Summary of the filing
Lakefront Biotherapeutics filed a Form 6-K attaching a press release dated November 10, 2026. The filing text does not disclose the contents of the press release.
Key details
How LKFT stock reacted
Close before
$33.34
Nov 11, 2026
First close after
+1.77%
$33.93
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for LKFT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LKFT?
Click hereFrequently asked questions
What did LKFT file with the SEC on Nov 12, 2026?
LKFT filed a 6-K (SEC filing). Lakefront Biotherapeutics filed a Form 6-K attaching a press release dated November 10, 2026. The filing text does not disclose the contents of the press release.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
How did LKFT stock react to this filing?
LKFT closed at $33.34 before the filing and $33.93 on Nov 12, 2026 (+1.77%).
Other LKFT SEC filings
Get alerts when LKFT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days